Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer
Clinical trial NCT04419402 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04419402
- Sponsor
- Australian and New Zealand Urogenital and Prostate Cancer Trials Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-17
- Primary completion
- 2024-04-12
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.